Deliverables

More detailed evaluation findings will soon be published in the D.9.2 Final ADLIFE evaluation report.

WP 1: Coordination and management

• D1.1 Data Management Plan, 31/8/2020
  This document is the data management plan of the ADLIFE project. It presents the intended data processing and flows, and specifies the intentions of the project to make open research data available at the end of the project.

• D1.1 Data Management Plan, 30/6/2023
  This document is the updated version of the data management plan of the ADLIFE project. It presents the implemented data processing and flows, and specifies the intentions of the project to make open research data available at the end of the project.

WP 2: Communication and dissemination

• D2.1 Communication and Dissemination Plan and Communication Material, 30/6/2020
  This strategy aims to plan, organise and evaluate key communication and dissemination activities undertaken by the consortium for the promotion of ADLIFE's results and findings, including the diffusion of innovations generated, to targeted audiences.

• D2.3 Final Report on Dissemination Activities, 30/11/2024
  This deliverable includes the final report of ADLIFE project dissemination and communication activities.

WP 6: Evidence-Based Personalised Care Delivery

• D6.1 Decision Support Modules Scopes and Content, 30/9/2021
  This deliverable describes the scopes and the content of the Clinical Decision Support Services (CDSS) to be used in ADLIFE.

• D6.2 Recommendations for Change Management in Integrated Personalized Care Delivery, 30/6/2022
  This deliverable describes the scope and strategies for change management to be used in ADLIFE.

WP 7: Empowerment of patients, caregivers and communities

• D7.1 Patient-reported Outcome Measures, 31/1/2021
  This deliverable presents the activities that have been conducted aimed at the identification, selection and definition of the PROMs that will be deployed in Patient Empowerment Platform (PEP) to be used by the seven pilot sites during the ADLIFE intervention.

• D7.2 Patient Empowerment Materials and Interventions, 31/7/2021
  This deliverable presents the sum of activities that has been performed on the topic of patient empowerment as part of task 7.2.

WP 8: Pilot Design & Implementation

• D8.1 ADLIFE Deployment Plans, 30/6/2022
  This deliverable describes the process and interim outcomes of the development of the plans for the deployment of the ADLIFE pilot in all of the pilot sites. It delineates the objectives of the deployment plans, and the methodology used within the consortium for developing the plans for deployment at both the overall project level as well as the individual pilot site level.

• D8.2 - Report of Pilot Execution, 31/07/2024
  This deliverable describes the implementation and execution of the ADLIFE pilots, the original plans as detailed in the DOA, the challenges encountered, the changes made, the final details of the actual operation of the pilots and the lessons learned.

WP 9: Evaluation

• D9.1 ADLIFE Intermediate Progress Report, 30/6/2023
  This deliverable presents the work that has been conducted by WP9 on the evaluation of the ADLIFE intervention and the risk prediction models.

• D9.2 - Final evaluation report, 30/11/2024
  This deliverable presents the work that has been conducted by WP9 on the evaluation of ADLIFE.

WP 10: Exploitation and dissemination

• D10.1 Exploitation Plan, 30/6/2020
  This deliverable presents the both non-commercial and commercial efforts to maximize the exploitation of the innovative findings.

• D10.2 - Business Plans for the Innovative Findings, 30/11/2024
  This deliverable describes all the work conducted concerning the exploitation in the project. It specifically focuses on the business plans as part of T10.5.